New York 2025-2026 Regular Session

New York Assembly Bill A02289

Introduced
1/16/25  

Caption

Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

Companion Bills

NY S00488

Same As Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

Similar Bills

UT SB0273

State Settlement Agreements Requirements

AZ HB2275

Settlement agreements; report; approval

CA AB560

Sustainable Groundwater Management Act: groundwater adjudication.

AZ HB2222

Settlement agreements; report; approval

NJ A954

Requires settlement agreements concerning equal employment opportunity to be approved by NJT board of directors.

NJ A232

Requires settlement agreements concerning equal employment opportunity to be approved by NJT board of directors.

NJ S927

Requires settlement agreements concerning equal employment opportunity to be approved by NJT board of directors.

MS HB864

MS Statutory Thresholds for Settlements Involving Minors Act; create with affidavit requirements.